BioCircuit Technologies Inc. – Trademark Portfolio
Entity Type: 03
BioCircuit Technologies Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 6 are pending. Notable registered marks include BIOCIRCUIT and NERVE TAPE. The owner is based in Atlanta, GA.
1819 Peachtree Rd NE
Atlanta, GA 30319
Showing of trademarks Trademarks
Trademark Classifications
BioCircuit Technologies Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BioCircuit Technologies Inc. have?
BioCircuit Technologies Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 pending, 1 abandoned.
What trademark classes does BioCircuit Technologies Inc. file in?
BioCircuit Technologies Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are BioCircuit Technologies Inc.'s most well-known trademarks?
BioCircuit Technologies Inc.'s registered trademark portfolio includes well-known marks such as BIOCIRCUIT and NERVE TAPE. These are among 2 currently registered trademarks in the portfolio.
What is BioCircuit Technologies Inc.'s trademark registration success rate?
BioCircuit Technologies Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 6 applications are pending review.